@prefix dcterms: . @prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix schem: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:9588; a Protein: . sub:_2 occursIn: species:9606; rdf:object schem:Phosphatidylinositol-3%2C4%2C5-trisphosphate; rdf:predicate belv:decreases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(HGNC:PTEN) -| a(SCHEM:\"Phosphatidylinositol-3,4,5-trisphosphate\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "1.4" . sub:_3 prov:value "Activity of this pathway is also determined by phosphatidylinositol- 3-phosphates such as phosphatase and tensin homologue43 and the SH2 domain-containing inositol-5-phosphatase SHIP2 (ref. 44). Overexpression of these enzymes leads to decreased levels of PtdIns(3,4,5)P3. This might terminate signal transduction and/or change the nature of the phosphoinositides, altering the binding specificity to PH or phox homology domains."; prov:wasQuotedFrom pubmed:11742412 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:11742412; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dcterms:created "2014-07-03T14:29:59.604+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }